Label: DR. RECKEWEG R59 VESICULINE COMBINATION PRODUCT- calcarea carbonica 12x, fucus vesiculosus 4x, graphites 12x, natrum sulphuricum 4x, spongia tosta 4x liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved homeopathic

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated April 4, 2013

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active ingredients

    Calcarea carbonica 12X, Fucus vesiculosus 4X, Graphites 12X, Natrum sulphuricum 4X, Spongia tosta 4X, 1 g each in 10 g. 

  • PURPOSE


    Purpose

    Relieves symptoms associated with weight gain due to glandular dysfunction



  • INDICATIONS & USAGE


    Uses

    For the temporary relief of minor symptoms associated with:


    • Weight gain due to glandular dysfunction

  • WARNINGS

    Warnings

    Do not use

    • if you are hypersensitive to iodine
    • if you have a thyroid condition (e.g. hypothyroidism or hyperthyroidism)
    • if you are pregnant or breastfeeding
    • in cases with intestinal affections

    Stop use and ask a doctor if symptoms persist, get worse, or if new symptoms occur.

    Keep out of reach of children.

  • DOSAGE & ADMINISTRATION


    Directions 

    Adults and children ≥ 12 years 5-10 drops 1-3 times daily in a little water or undiluted or as recommended.

  • OTHER SAFETY INFORMATION


    Other information

    • Tamper resistant: do not use if safety ring at base of cap is broken.
    • Retain outer carton for full product instructions.

  • INACTIVE INGREDIENT

    Inactive ingredients

    Ethanol, purified water.

  • QUESTIONS

    Questions?
    Call 1-800-361-7872 or email questions@reckeweg.com

  • PRINCIPAL DISPLAY PANEL


    image of carton label

    NDC# 53346-1359-5

    Dr. Reckeweg R59 Vesiculine

    Homeopathic preparation for the temporary relief of minor symptoms associated with:

    • Weight gain due to glandular dysfunction

    Manufactured by:

    Dr. Reckeweg Co. GmbH

    D-64625 Bensheim

    Germany


    1.68 fl oz
    (50 ml)

  • INGREDIENTS AND APPEARANCE
    DR. RECKEWEG R59 VESICULINE  COMBINATION PRODUCT
    calcarea carbonica 12x, fucus vesiculosus 4x, graphites 12x, natrum sulphuricum 4x, spongia tosta 4x liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53346-1359
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OYSTER SHELL CALCIUM CARBONATE, CRUDE (UNII: 2E32821G6I) (OYSTER SHELL CALCIUM CARBONATE, CRUDE - UNII:2E32821G6I) OYSTER SHELL CALCIUM CARBONATE, CRUDE12 [hp_X]  in 50 mL
    FUCUS VESICULOSUS (UNII: 535G2ABX9M) (FUCUS VESICULOSUS - UNII:535G2ABX9M) FUCUS VESICULOSUS4 [hp_X]  in 50 mL
    GRAPHITE (UNII: 4QQN74LH4O) (GRAPHITE - UNII:4QQN74LH4O) GRAPHITE12 [hp_X]  in 50 mL
    SODIUM SULFATE (UNII: 0YPR65R21J) (SODIUM SULFATE ANHYDROUS - UNII:36KCS0R750) SODIUM SULFATE4 [hp_X]  in 50 mL
    SPONGIA OFFICINALIS SKELETON, ROASTED (UNII: 1PIP394IID) (SPONGIA OFFICINALIS SKELETON, ROASTED - UNII:1PIP394IID) SPONGIA OFFICINALIS SKELETON, ROASTED4 [hp_X]  in 50 mL
    Inactive Ingredients
    Ingredient NameStrength
    ALCOHOL (UNII: 3K9958V90M)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:53346-1359-550 mL in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic06/01/1986
    Labeler - PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO (318602612)
    Establishment
    NameAddressID/FEIBusiness Operations
    PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO318602612manufacture(53346-1359)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!